Abstract:When Joseph Priestley discovered oxygen in 1774, he found that air was a mixture of gases. He called one of these gases “dephlogisticated air,” to which later the chemist Antoine Lavoisier gave the name “oxygen” which made candles burn brighter and longer than ordinary air [1]. Until now, this discovery covers 2 essential features of oxygen which in clinical practice results in the use of oxygen as a drug. In clinical practice, oxygen can be life-saving by giving to patients with tissue hypoxemia. However, too much oxygenation can cause toxicity, which has been well described in the literature. Oxygen toxicity in central nervous system is termed Paul Bert effect and in the lung it is termed Lorrain Smith effect. The Paul Bert effect results in seizures from which the onset depends upon the partial pressure of oxygen in the breathing gas and exposure duration. This effect is well known among divers and in hyperbaric facilities. Respiratory side effects from oxygen are more frequently observed in critical care settings resulting in a restrictive policy not to administer more oxygen than required. In this context, however, it is important to have the formulae of oxygen content in mind while not just relying on the oxygen saturation values (arterial oxygen content = (Hb × 1.34 × SaO 2 ) + (0.0031 × PaO 2 )). Additionally, NICU patients are potentially at risk for Terry’s syndrome or retinopathy of prematurity, a disease of the eye when oxygen is administered for premature development of the lungs. Although oxygen is a natural molecule, the complexity of its interactions with human metabolism continues to be a subject for in-depth research [2]. In this thematic issue of oxygen therapy and ventilatory support (OTVS), several papers investigated and discussed some key aspects in the field of respiratory failure and ventilator support. J.-L. Vincent et al. published an article addressing the harmful effect of hyperoxia on critical illness. It has been reported that the effect of partial pressure of arterial oxygenation on mortality follows a quadratic function [3], and there is nadir at which the mortality rate is the lowest. Respiratory support can be performed by a variety of techniques, ranging from the simple oxygen therapy to complex extracorporeal membrane oxygenation (ECMO). In patients with ECMO, the mechanical ventilation usually plays an important role. The appropriate setting of the ventilator is of vital importance to provide oxygen supply to vital organs while avoiding lung injury. It is an art and science where, in most circumstances, there is a lack of high-level evidence from randomized controlled trials. Z. Zhang and colleagues discussed some important aspects on the use of mechanical ventilation in patients with ECMO. S. Ye and his colleagues investigated the effect of antipyretic therapy on mortality outcome in patients receiving mechanical ventilation. The study employed the MIMIC-II database as the source of data [4]. The database is freely available to the public and is the gold standard of the critical care big data. It provides in-hospital clinical data with high granularity, and data mining using such database can provide insights into complex interactions between disease severity, medical treatment, and procedures. Such complex interactions may not be feasible in conventional randomized controlled trials (RCTs). Also, traditional RCTs are designed to explore the biological efficacy of a certain intervention, which may not be applicable to real world settings where the clinical effectiveness is most highlighted. There is evidence that the results obtained fromRCTs can be different from that obtained by observational studies [5].

Right Ventricular Assist Device with an Oxygenator for the Management of Combined Right Ventricular and Respiratory Failure: A Systematic Review.

Oxygenated Right Ventricular Assist Device (OxyRVAD): The Right Bridge for Severe Respiratory and Right Ventricular Failure?

Oxygenated right ventricular assist device as part of veno-venopulmonary extracorporeal membrane oxygenation to support the right ventricle and pulmonary vasculature

Experience with percutaneous right ventricular support in the early post-left ventricular assist device implantation period (clinical case report and literature reviews)

Mechanical Ventilation during Extracorporeal Membrane Oxygenation in Patients with Acute Severe Respiratory Failure

EC-VAD: Combined Use of Extracorporeal Membrane Oxygenation and Percutaneous Microaxial Pump Left Ventricular Assist Device

Percutaneous venopulmonary artery extracorporeal membrane oxygenation for right heart failure after left ventricular assist device insertion

A Systematic Review and Description of Configurations

Oxygen Therapy and Ventilatory Support

Preemptive temporary right ventricular assist device implantation for severe biventricular heart failure: A case series

Refractory cor pulmonale under extracorporeal membrane oxygenation for acute respiratory distress syndrome: the role of conversion to veno-pulmonary arterial assist—a case series

Novel Left Ventricular Unloading Strategies in Patients on Peripheral Venoarterial Extracorporeal Membrane Oxygenation Support

Medical Optimization and Liberation of Adult Patients From VA-ECMO

Right Ventricular Function in Acute Respiratory Distress Syndrome: Impact on Outcome, Respiratory Strategy and Use of Veno-Venous Extracorporeal Membrane Oxygenation

[When mechanical ventilation fails-Venovenous extracorporeal membrane oxygenation]

The use of protective mechanical ventilation during extracorporeal membrane oxygenation for the treatment of acute respiratory failure

Outcomes following additional drainage during veno-venous extracorporeal membrane oxygenation: A single-center retrospective study

Safety And Efficacy Of Impella RP Support For Acute Right Ventricular Failure Complicated By Cardiogenic Shock: Post Market Approval Sub-Analysis Of The CVAD Registry

Right Ventricular Assist Device Placement During Left Ventricular Assist Device Implantation Is Associated With Improved Survival

A Prospective Observational Comparative Study

Left ventricular unloading via percutaneous assist device during extracorporeal membrane oxygenation in acute myocardial infarction and cardiac arrest